Company & Sponsor Intelligence
Centre Hospitalier Universitaire de Nīmes
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting1
Completed2
Countries1
Therapeutic footprint
alzheimersother_psychiatrysubstance_use
Indexed studies
NCT05930353Psychometric Validation of a French-language Version of the PERMA-Profiler: Tools for Assessing Multidimensional Subjective Well-being
other_psychiatry · FranceNOT_YET_RECRUITING
other_psychiatry · FranceNOT_YET_RECRUITING
NCT02664571Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial Hemosiderosis
alzheimers · FranceNA
alzheimers · FranceNA
NCT04007042Validation of a Short Questionnaire (SSI) for Sleep Disorders in Patients With Alcohol
substance_use · FranceCOMPLETED
substance_use · FranceCOMPLETED
NCT02329626Metabolic Anomolies Associated With the 6 Month Clinical Evolution of Patients Suffering From Motor Conversion Disorder
other_psychiatry · FranceCOMPLETED
other_psychiatry · FranceCOMPLETED
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →